A137 THERAPEUTIC DRUG MONITORING WITH INFLIXIMAB TROUGH LEVELS LEAD TO INCREASED INTERVENTION

BACKGROUND: Therapeutic drug monitoring (TDM) of infliximab (IFX) as indicated in patients with loss of response (LOR) (known as reactive strategy) is a widely accepted strategy in the management of patients with inflammatory bowel disease (IBD). Proactive drug monitoring of IFX trough levels has be...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Can Assoc Gastroenterol
Main Authors: Stern, N C, Fedorak, R, Wong, K, Halloran, B P, Dieleman, L A, Huang, V, Peerani, F, Kroeker, K I
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Paper Sessions
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6508429/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy009.137
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados